Application of Tramadol Analgesia after Off-Pump Coronary Artery Bypass Graft Surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002125

Enrollment

Unknown

Registered

2012-03-23

Start date

2011-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Off-pump Coronary Artery Bypass Graft Surgery postoperative Analgesia

Interventions

Tramadol Group:tramadol as postoperative analgesia

Sufentanil Group:sufentanil as postoperative analgesia

Eligibility

Sex/Gender

All

Age

38 Years to 75 Years

Inclusion criteria

Inclusion criteria: Fifty-two consecutive patients undergoing OPCAB under standard sufentanil-based general anesthesia in Peking University People's Hospital.

Exclusion criteria

Exclusion criteria: Exclusion criteria, Left ventricular ejection fraction less than 40%, emergency, Intra-aortic balloon pump application before surgery, congestive heart failure, chronic pain, mental disorder, being allergic to tramadol or sufentanil, severe kidney or liver disease, coagulopathy, drug abuse or alcohol abuse.

Design outcomes

Primary

Measure	Time frame
postoperative pain scor;	—

Countries

China

Contacts

Public ContactZhao Hong

rayezhao@gmail.com+86 010 88325581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026